9 published brand profiles in this category. Cite the individual brand profile for brand-specific facts.
Anaptysbio - Strategic stewardship of financial collaborations to deliver shareholder value AnaptysBio exclusively manages the financial collaborations from Jemperli with GSK and imsidolimab with Vanda, with a focus on protecting and returning their value to stockholdersVirtual operating modelLess than ~10 FTEs operating as contractors to support the essential functions of a public companyAnticipate annualized
Galecto - Damora Therapeutics is working to fundamentally redefine care for people with blood disorders by bringing forward optimized therapies that dramatically improve patient outcomes.
Galera Therapeutics - Galera Therapeutics is an autoimmune company headquartered in Malvern, PA, founded in 2012.
Gossamer Bio - The name Gossamer Bio depicts the symbolism behind the gossamer thread, the fragile connection that binds all relationships in life. In our context, this is intended to highlight the importance of our relationships with patients, employees, shareholders, providers and partners. We take these relationships seriously and aim to strengthen these connections continuously.
Immunovant - Immunovant is an autoimmune company headquartered in New York, NY, founded in 2018.
Kyverna Therapeutics - Discover Kyverna, a patient-centered, clinical-stage biopharmaceutical company with active, ongoing clinical trials for multiple autoimmune diseases at different locations across the world.
Landos Biopharma - About the NEXUS StudyNEXUS is a Phase 2 proof-of-concept clinical trial evaluating NX-13 in patients with moderate to severe UC. NEXUS is a randomized, multicenter, double-blind, placebo-controlled, multiple dose, 12-week induction study evaluating 80 patients with moderate to severe UC with a long-term extension (LTE) period. All subjects will be randomized to receive either 250 mg or 750 mg immediate release NX-13, or placebo.
Pandion Therapeutics - Pandion Therapeutics is an autoimmune company headquartered in Watertown, MA, founded in 2017.
Protagonist Therapeutics - Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.